These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 27458370)

  • 1. Mechanisms of Aβ Clearance and Degradation by Glial Cells.
    Ries M; Sastre M
    Front Aging Neurosci; 2016; 8():160. PubMed ID: 27458370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoproteins E and J interfere with amyloid-beta uptake by primary human astrocytes and microglia in vitro.
    Mulder SD; Nielsen HM; Blankenstein MA; Eikelenboom P; Veerhuis R
    Glia; 2014 Apr; 62(4):493-503. PubMed ID: 24446231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental approaches for altering the expression of Abeta-degrading enzymes.
    Loeffler DA
    J Neurochem; 2023 Mar; 164(6):725-763. PubMed ID: 36633092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition.
    Liu CC; Hu J; Zhao N; Wang J; Wang N; Cirrito JR; Kanekiyo T; Holtzman DM; Bu G
    J Neurosci; 2017 Apr; 37(15):4023-4031. PubMed ID: 28275161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-signaling Pathway Regulates the Degradation of Amyloid β-protein via Astrocytes.
    Yamamoto N; Ishikuro R; Tanida M; Suzuki K; Ikeda-Matsuo Y; Sobue K
    Neuroscience; 2018 Aug; 385():227-236. PubMed ID: 29932983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Powering Amyloid Beta Degrading Enzymes: A Possible Therapy for Alzheimer's Disease.
    Sikanyika NL; Parkington HC; Smith AI; Kuruppu S
    Neurochem Res; 2019 Jun; 44(6):1289-1296. PubMed ID: 30806879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple cellular and molecular mechanisms are involved in human Aβ clearance by transplanted adult astrocytes.
    Pihlaja R; Koistinaho J; Kauppinen R; Sandholm J; Tanila H; Koistinaho M
    Glia; 2011 Nov; 59(11):1643-57. PubMed ID: 21826742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-amyloid induces the production of active, matrix-degrading proteases in cultured rat astrocytes.
    Deb S; Wenjun Zhang J; Gottschall PE
    Brain Res; 2003 Apr; 970(1-2):205-13. PubMed ID: 12706262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression Pattern of Scavenger Receptors and Amyloid-β Phagocytosis of Astrocytes and Microglia in Culture are Modified by Acidosis: Implications for Alzheimer's Disease.
    Eugenín J; Vecchiola A; Murgas P; Arroyo P; Cornejo F; von Bernhardi R
    J Alzheimers Dis; 2016 May; 53(3):857-73. PubMed ID: 27258416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPR120 Signaling Controls Amyloid-β Degrading Activity of Matrix Metalloproteinases.
    Kikuchi K; Tatebe T; Sudo Y; Yokoyama M; Kidana K; Chiu YW; Takatori S; Arita M; Hori Y; Tomita T
    J Neurosci; 2021 Jul; 41(28):6173-6185. PubMed ID: 34099509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer's Disease.
    Yoon SS; Jo SA
    Biomol Ther (Seoul); 2012 May; 20(3):245-55. PubMed ID: 24130920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin and atorvastatin facilitates amyloid β-protein degradation in extracellular spaces by increasing neprilysin secretion from astrocytes through activation of MAPK/Erk1/2 pathways.
    Yamamoto N; Fujii Y; Kasahara R; Tanida M; Ohora K; Ono Y; Suzuki K; Sobue K
    Glia; 2016 Jun; 64(6):952-62. PubMed ID: 26875818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes.
    Miners JS; Palmer JC; Tayler H; Palmer LE; Ashby E; Kehoe PG; Love S
    Front Aging Neurosci; 2014; 6():238. PubMed ID: 25309424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid-beta neurotoxicity and clearance are both regulated by glial group II metabotropic glutamate receptors.
    Durand D; Carniglia L; Turati J; Ramírez D; Saba J; Caruso C; Lasaga M
    Neuropharmacology; 2017 Sep; 123():274-286. PubMed ID: 28495373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-inflammatory Annexin A1 induces the clearance and degradation of the amyloid-β peptide.
    Ries M; Loiola R; Shah UN; Gentleman SM; Solito E; Sastre M
    J Neuroinflammation; 2016 Sep; 13(1):234. PubMed ID: 27590054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigallocatechin gallate induces extracellular degradation of amyloid β-protein by increasing neprilysin secretion from astrocytes through activation of ERK and PI3K pathways.
    Yamamoto N; Shibata M; Ishikuro R; Tanida M; Taniguchi Y; Ikeda-Matsuo Y; Sobue K
    Neuroscience; 2017 Oct; 362():70-78. PubMed ID: 28844000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting amyloid-degrading enzymes as therapeutic strategies in neurodegeneration.
    Turner AJ; Fisk L; Nalivaeva NN
    Ann N Y Acad Sci; 2004 Dec; 1035():1-20. PubMed ID: 15681797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring glia to better understand Alzheimer's disease.
    Kim YS; Jung HM; Yoon BE
    Anim Cells Syst (Seoul); 2018; 22(4):213-218. PubMed ID: 30460100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.